There is an association between ADAM33 and inflammation in COPD patients as indicated by the correlation of ADAM33 with MMP-9 and cytokine levels (IL-6, IL-8 and IL-10) in COPD patients. Here, MMP9 is linked to chronic obstructive pulmonary disease.